Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04079608 · ClinicalTrials.gov registry record · NA
Rigorous Evaluation of High School FLASH
A NA study, sponsored by ETR Associates.
- Completed
- Registry status
- NA
- Development phase
- 1,597
- Enrollment target
NCT04079608: Completed NA study, sponsored by ETR Associates.
NCT04079608 is a NA study that has completed, run by ETR Associates. The registered enrollment target is 1,597 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04079608, a NA study, has completed, sponsored by ETR Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,597 participants
- Enrollment target
Study Summary
High School FLASH is a 15-session comprehensive sexual health curriculum designed for classroom settings in grades 9 to 12. The basis of High School FLASH is a public health approach to behavior change. The primary strategy used in the FLASH curriculum for preventing teen pregnancy, sexually transmitted diseases (STDs), and sexual violence is to address student behaviors and attitudes. To this end, FLASH uses a harm reduction and behavior change framework, implements best practices as outlined in the research on effective programs, addresses risk and protective factors for program goals, and rests on the theory of planned behavior. The instructional approach of High School FLASH employs key concepts in every lesson, which enables teachers to hone in on the risk and protective factors outlined in the curriculum logic model. The curriculum covers the following topics: reproductive system, pregnancy, sexual orientation and gender identity, healthy relationships, coercion and consent, online safety, abstinence, birth control, preventing human immunodeficiency virus (HIV) and other STDs, condoms, STD testing, communicating and decision making, and improving school health. The curriculum aligns with national health education standards.
Primary Outcome
Measured with a single item required and provided by the funder: "In the past 3 months, have you had vaginal intercourse, even once?" Yes/No
Interventions
- BEHAVIORAL FLASH curriculum
- BEHAVIORAL Sexual Health Education for Adolescents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,597 participants |
| Start Date | 2016-10-05 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
What the finished NCT04079608 record still lists
NCT04079608 is an interventional study that assigns participants to a tested intervention. Its 1,597 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher).
The record links to 0 conditions, and to 2 interventions - of which FLASH curriculum is the first listed.
NCT04079608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04079608 about?
NCT04079608 is a clinical study titled "Rigorous Evaluation of High School FLASH". High School FLASH is a 15-session comprehensive sexual health curriculum designed for classroom settings in grades 9 to 12. The basis of High School FLASH is a public health approach to behavior change. The primary strategy used in the FLASH curriculum for preventing teen pregnancy, sexually transmi...
What is the current status of trial NCT04079608?
This trial is currently completed. It is a NA study. The enrollment target is 1,597 participants. The study started on 2016-10-05. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT04079608?
The interventions under investigation include: FLASH curriculum (BEHAVIORAL), Sexual Health Education for Adolescents (BEHAVIORAL).
Who is sponsoring clinical trial NCT04079608?
This trial is sponsored by ETR Associates, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04079608's enrollment target sits among peer trials
1,597 64th of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI